2020 annual financial data

Aligos Therapeutics, Inc. 2020 Net margin

Aligos Therapeutics, Inc. 2020 net margin with verified reported values.

Direct answer

Net margin was 1,029.04%.

Operating income was -97,834,000 USD and net income was -108,543,000 USD.
Operating cash flow was -74,263,000 USD.

Get free Aligos Therapeutics, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
-10,548,000 USD
Operating income
-97,834,000 USD
Net income
-108,543,000 USD
Operating cash flow
-74,263,000 USD